Down 25%, Should Bristol Be a Dip Buy Right Now Today?
When a blue-chip pharma stock falls 25%, many investors wonder if it's time to buy. This guide breaks down how to ass...
Financial planning basics lay the foundation for effective money management. Learn essential concepts to enhance your financial health.
17,896 articlesWhen a blue-chip pharma stock falls 25%, many investors wonder if it's time to buy. This guide breaks down how to ass...
CHLA pushes for an FHA pilot that would pay lenders directly for sub-$100K mortgages, arguing the move is needed to u...
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
As AI and data centers expand, memory demand fuels Micron's growth. This article explains why micron technology: memo...
Federal Reserve Governor Christopher Waller argued that the February payrolls report, not a Supreme Court tariff ruli...
As quantum dreams grow from labs to law and logistics, Rigetti's domestic footprint and government ties could propel ...
A heated public dispute over tariffs erupts after a Supreme Court ruling on emergency tariffs, with Treasury Secretar...
SK Hynix shares rebound 8% amid bargain-hunting after HSBC reaffirmed SKHY as a top chip pick. The move comes as inve...
Stocks faced a rough start to the week as tariff headlines rattled markets and Nvidia prepares its earnings reveal. L...
As Iran escalates into conflict 2.0 and mortgage rates linger near the sixes, the housing market faces new tests. Thi...
A new AI-driven marketing platform is raising Reg A+ funds at $0.85 per share, pitching a fast-growth TMT play for in...
In 2026, investors face a choice between rapid disruption and steady government contracts. This article compares Spac...